Thus, this review comprehensively summarizes preclinical and clinical reports of the roles of FGF23 on osteoporosis and chronic kidney disease–mineral and bone disease (CKD-MBD), with an emphasis on the local actions, as opposed to systemic actions, of FGF23 on the bone. This evidence concerns the gene FGF23 and osteoporosis.